百克生物
(688276)
| 流通市值：75.16亿 | | | 总市值：75.16亿 |
| 流通股本：4.14亿 | | | 总股本：4.14亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 215,465,506.39 | 201,237,558.03 | 157,439,788.29 | 246,759,293.74 |
| 应收票据及应收账款 | 924,019,058.73 | 936,821,269.35 | 1,183,060,098.55 | 1,176,692,608.36 |
| 应收账款 | 924,019,058.73 | 936,821,269.35 | 1,183,060,098.55 | 1,176,692,608.36 |
| 预付款项 | 42,145,555.01 | 41,017,692.99 | 37,311,452.59 | 44,095,018.41 |
| 其他应收款合计 | 1,657,445.93 | 1,511,121.27 | 2,000,308.57 | 1,910,253.33 |
| 存货 | 273,532,582.98 | 226,553,578.52 | 232,401,508 | 278,753,114 |
| 其他流动资产 | 23,258,948.41 | 15,783,599.31 | 23,636,835.63 | 32,863,553.84 |
| 流动资产合计 | 1,480,079,097.45 | 1,422,924,819.47 | 1,635,849,991.63 | 1,781,073,841.68 |
| 非流动资产: | | | | |
| 长期股权投资 | 339,539,516.51 | 349,675,441.43 | 359,471,539.14 | 368,508,767.8 |
| 其他权益工具投资 | 12,096,628.13 | 14,673,089.3 | 17,682,019.14 | 20,630,607.33 |
| 固定资产 | 981,105,520.41 | 1,012,157,859.74 | 1,030,175,422.18 | 1,051,917,994.1 |
| 在建工程 | 1,637,116,686.73 | 1,600,738,797.1 | 1,537,956,925.57 | 1,495,505,460.53 |
| 无形资产 | 308,308,214.12 | 320,620,042.97 | 328,258,881.56 | 300,358,523.26 |
| 开发支出 | 94,451,317.9 | 71,744,266.16 | 39,356,465.88 | 5,033,579.69 |
| 长期待摊费用 | 75,732,534.7 | 82,210,334.15 | 88,506,631.71 | 66,768,347.13 |
| 递延所得税资产 | 167,990,896.94 | 163,559,679.95 | 140,135,532.62 | 119,425,642.69 |
| 其他非流动资产 | 31,463,710.13 | 30,116,947.83 | 32,803,234.62 | 55,464,508.54 |
| 非流动资产合计 | 3,647,805,025.57 | 3,645,496,458.63 | 3,574,346,652.42 | 3,483,613,431.07 |
| 资产总计 | 5,127,884,123.02 | 5,068,421,278.1 | 5,210,196,644.05 | 5,264,687,272.75 |
| 流动负债: | | | | |
| 短期借款 | 237,867,754.02 | 181,185,888.03 | 204,186,410.91 | 155,537,203.6 |
| 应付票据及应付账款 | 30,073,659.66 | 19,602,304.48 | 25,202,326.88 | 27,797,150.37 |
| 应付账款 | 30,073,659.66 | 19,602,304.48 | 25,202,326.88 | 27,797,150.37 |
| 合同负债 | 12,841,805.78 | 11,924,128.55 | 1,050,741.54 | 1,027,119.76 |
| 应付职工薪酬 | 20,790,153.22 | 29,452,202.39 | 27,836,777.86 | 28,214,009.54 |
| 应交税费 | 615,371.77 | 841,571.19 | 1,978,816.59 | 973,461.04 |
| 其他应付款合计 | 792,187,605.54 | 799,053,713.07 | 817,329,474.84 | 852,984,435.89 |
| 一年内到期的非流动负债 | 21,935,722.8 | 20,467,777.94 | 21,485,679.92 | - |
| 其他流动负债 | 38,620,495.34 | 42,313,828.08 | 73,817,216.6 | 9,469,024.85 |
| 流动负债合计 | 1,154,932,568.13 | 1,104,841,413.73 | 1,172,887,445.14 | 1,076,002,405.05 |
| 非流动负债: | | | | |
| 长期借款 | 78,651,363.97 | 63,584,094.16 | 70,415,797.86 | 107,844,630.08 |
| 预计负债 | 2,282 | 2,282 | 2,282 | 259,734.26 |
| 递延收益 | 48,173,530.24 | 48,264,191.93 | 8,485,515.95 | 8,436,692.08 |
| 递延所得税负债 | 756,463.06 | 781,416.81 | 806,370.55 | 831,324.3 |
| 非流动负债合计 | 127,583,639.27 | 112,631,984.9 | 79,709,966.36 | 117,372,380.72 |
| 负债合计 | 1,282,516,207.4 | 1,217,473,398.63 | 1,252,597,411.5 | 1,193,374,785.77 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 413,657,598 | 413,657,598 | 413,657,598 | 413,657,598 |
| 资本公积 | 1,817,757,897.45 | 1,817,673,725.65 | 1,817,437,284.1 | 1,843,967,146.68 |
| 其他综合收益 | -39,017,866.11 | -36,827,874.12 | -34,270,283.75 | -31,763,983.79 |
| 盈余公积 | 533,475,182 | 533,475,182 | 533,475,182 | 533,475,182 |
| 未分配利润 | 1,119,495,104.28 | 1,122,969,247.94 | 1,227,299,452.2 | 1,311,976,544.09 |
| 归属于母公司股东权益合计 | 3,845,367,915.62 | 3,850,947,879.47 | 3,957,599,232.55 | 4,071,312,486.98 |
| 股东权益合计 | 3,845,367,915.62 | 3,850,947,879.47 | 3,957,599,232.55 | 4,071,312,486.98 |
| 负债和股东权益合计 | 5,127,884,123.02 | 5,068,421,278.1 | 5,210,196,644.05 | 5,264,687,272.75 |
| 公告日期 | 2026-04-22 | 2026-04-22 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |